CNI Latest Quarter's Earnings
| Announce Date | 05/01/2025 |
| EPS Normalized Actual | $1.29 (Beat by $0.03) |
| EPS GAAP Actual | $1.29 (Beat by $0.03) |
| Revenue Actual | $4.403B |
| Revenue Surprise | Beat by $4403M |
Upcoming Quarter's Earnings
| Announce Date | 09/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.30255 |
| EPS GAAP Estimate | $2.30255 |
| Revenue Estimate | $3.44959879B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 11.82129 | 9.03 | 11.21964 | 12.57173 | 8 |
| Dec 2028 | 12.30256 | 8.68 | 11.78351 | 12.93376 | 9 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 1.85 | -0.08534 | 4.403B | 3.5% | 1043.87M |
| FQ4 2024 (Dec 2024) | 1.8 | 1.8 | 4.358B | -2.59% | 4358M |
| FQ3 2024 (Sep 2024) | 1.71 | 1.71 | 4.11B | 2.99% | 4110M |
| FQ2 2024 (Jun 2024) | 1.75 | 1.75 | 4.329B | 6.28% | 4329M |
| FQ1 2024 (Mar 2024) | 1.72 | 1.72 | 4.249B | -1.51% | 4249M |
| FQ4 2023 (Dec 2023) | 3.2952 | 3.2952 | 4.471B | -1.59% | 4471M |
| FQ3 2023 (Sep 2023) | 1.69 | 1.69 | 3.987B | -13.19% | 3987M |
| FQ2 2023 (Jun 2023) | 1.76 | 1.76 | 4.057B | 100% | 4057M |
Quarterly Estimates Summary
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.30255
Consensus Revenue Estimates
3.44959879B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 2.75802 | -- | 2.60681 | 2.91056 | 20 |
| FQ2 2028 (Jun 2028) | 2.77513 | -- | 2.62299 | 2.92862 | 13 |
| FQ1 2028 (Mar 2028) | 2.56216 | -- | 2.42169 | 2.70387 | 19 |
| FQ4 2027 (Dec 2027) | 2.91138 | -- | 2.80998 | 3.02538 | 12 |
| FQ3 2027 (Sep 2027) | 2.8452 | -- | 2.67349 | 3.12282 | 10 |
| FQ2 2027 (Jun 2027) | 2.60334 | -- | 2.44622 | 2.85736 | 7 |
| FQ1 2027 (Mar 2027) | 2.22521 | -- | 2.14771 | 2.31234 | 8 |
| FQ4 2026 (Dec 2026) | 2.53376 | -- | 2.44551 | 2.63297 | 12 |
| FQ3 2026 (Sep 2026) | 2.59177 | -- | 2.46319 | 2.73301 | 9 |
| FQ2 2026 (Jun 2026) | 2.37952 | -- | 2.26147 | 2.50919 | 9 |
| FQ1 2026 (Mar 2026) | 2.04711 | 9.63 | 1.97581 | 2.12727 | 8 |
| FQ4 2025 (Dec 2025) | 2.35023 | 23.41 | 2.26837 | 2.44225 | 13 |
| FQ3 2025 (Sep 2025) | 2.30255 | 25.73 | 2.18832 | 2.42803 | 7 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 5.41B | -- | 5.18B | 5.64B | 11 |
| FQ2 2028 (Jun 2028) | 5.39B | -- | 5.16B | 5.62B | 11 |
| FQ1 2028 (Mar 2028) | 5.41B | -- | 5.19B | 5.64B | 11 |
| FQ4 2027 (Dec 2027) | 5.39B | -- | 5.25B | 5.55B | 7 |
| FQ3 2027 (Sep 2027) | 5.24B | -- | 5B | 5.64B | 7 |
| FQ2 2027 (Jun 2027) | 5.19B | -- | 4.95B | 5.58B | 7 |
| FQ1 2027 (Mar 2027) | 4.92B | -- | 4.79B | 5.07B | 7 |
| FQ4 2026 (Dec 2026) | 4.96B | -- | 4.83B | 5.11B | 9 |
| FQ3 2026 (Sep 2026) | 3.79B | -- | 3.65B | 3.95B | 7 |
| FQ2 2026 (Jun 2026) | 3.67B | -- | 3.53B | 3.83B | 12 |
| FQ1 2026 (Mar 2026) | 4.61B | 4.4 | 4.48B | 4.74B | 9 |
| FQ4 2025 (Dec 2025) | 4.79B | 9.1 | 4.67B | 4.94B | 13 |
| FQ3 2025 (Sep 2025) | 3.45B | -19.14 | 3.32B | 3.59B | 6 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 1.93534 | 1.85 | -0.08534 | -4.61% |
| FQ4 2024 (Dec 2024) | 1.8 | 1.8 | 100% | |
| FQ3 2024 (Sep 2024) | 1.71 | 1.71 | 100% | |
| FQ2 2024 (Jun 2024) | 1.75 | 1.75 | 100% | |
| FQ1 2024 (Mar 2024) | 1.72 | 1.72 | 100% | |
| FQ4 2023 (Dec 2023) | 3.2952 | 3.2952 | 100% | |
| FQ3 2023 (Sep 2023) | 1.69 | 1.69 | 100% | |
| FQ2 2023 (Jun 2023) | 1.76 | 1.76 | 100% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $3.36B | $4.4B | $1043.87M | 23.71% |
| FQ4 2024 (Dec 2024) | $0B | $4.36B | $4358M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $4.11B | $4110M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $4.33B | $4329M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $4.25B | $4249M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.47B | $4471M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $3.99B | $3987M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $4.06B | $4057M | 100% |
CNI Ratings Summary
CNI Quant Ranking
